SDC-1801 PK Simulator
Indication: Inflammatory and autoimmune diseases
Interactive phase 1 PK simulator for SDC-1801, an oral small-molecule TYK2/JAK1 inhibitor in development for inflammatory and autoimmune diseases. Shows fasted, fed, and repeated-dose exposure profiles for mechanism-aware PK interpretation.
Drug Overview
Clinical Context
- Molecular Target
- TYK2/JAK1
- Drug Class
- TYK2/JAK1 inhibitor
- Therapeutic Area
- Inflammation and Autoimmune Disease
- Indication
- Inflammatory and autoimmune diseases
- Route of Administration
- Oral
Model Information
- Model Type
- One-compartment oral PK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for SDC-1801 allows you to explore concentration-time profiles under different dosing scenarios. The underlying One-compartment oral PK model characterizes the pharmacokinetics of this tyk2/jak1 inhibitor following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the SDC-1801 PK simulator?
This is a free, interactive pharmacokinetic simulator for SDC-1801 used in Inflammatory and autoimmune diseases. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does SDC-1801 belong to?
SDC-1801 is classified as a TYK2/JAK1 inhibitor that targets TYK2/JAK1. It is used in the Inflammation and Autoimmune Disease therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of SDC-1801. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a One-compartment oral PK model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the SDC-1801 simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community